维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="FIGLIN R A"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The Usefulness of F-18 Deoxyglucose Whole-body Positron Emission Tomography (PET) for Re-staging of Renal Cell Cancer显示文摘	SAFAEI A FIGLIN R HOH CK	2002	Clin Nephrol2002，57，1：	1
2	Kidney cancer:progress and controversies in neoadjuvant therapy显示文摘	Posadas E M Figlin R A	2014	Nat Rev Urol2014，11，5：	1
3	Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-or显示文摘	PATIL S FIGLIN R A HUTSON T E	2012	Br J Cancer2012，106，15：	1
4	NCCN Task Force Re- port: mTOR inhibition in solid tumors显示文摘	Figlin R A Brown E Armstrong A J	2008	J Natl Compr Canc Netw2008，6，5：	1
5	Phase I trial of granulocyte macrophage-colony stimulating fac- tor and interleukin-4 as a combined imnmnotherapy for patients with cancer显示文摘	Gitlitz B J Figlin R A Kiertscher S M	2003	J Immunother2003，26，2：	1
6	ABX-EGF, a fully human anti-EGF receptor monoclonal antibody in patients with advanced cancer; phase I clinical results显示文摘	Figlin R A Belldegrum A S Crawford J	2002	Proc Am Soc Clin Oncol2002，21，：	1
7	A phase Ⅰ trial of CD3/CD28-activated T cells (X cellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma显示文摘	Thompson J A Figlin R A Sifri-Steele C	2003	Clin Cancer Res2003，9，10：	1
8	Targeted therapies for non- small cell lung cancer: an evolving landscape 显示文摘	PAL S K FIGLIN R A RECKAMP K	2010	Mol Cancer Ther2010，9，7：	1
9	: ABX-EGF, a fully human antiepidermal growth factor receptor (EGFR) monoclonal antibody (mAb) in patients with advanced cancer: phase 1 clinical results显示文摘	Figlin R Belldegrun A Crawford J	2002	Proc Am Soc Clin Oncol2002，21，：	1
10	Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma 显示文摘	Hudes G Cardueci M Tomczak P Duteher J Figlin R Kapoor A	2007	N Engl J Med2007，356，：	1
11	CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer显示文摘	Reckamp K L Figlin R A Burdick M D	2009	BMC Cancer2009，9，：	1
12	Surveillance strat- egies for renal cell carcinonla patients following nephrec- tomy 显示文摘	Chin A I Lam J S Figlin R A	2006	Reviews in urology2006，8，1：	1
13	Sunitinib ver-sus interferon-alfa (IFN-a) as first-line treatment of me-tastatic renal cell carcinoma ( mRCC) : Updated resultsand analysis of prognostic factors 显示文摘	MotzerR J Figlin R A Hutson T E	2008	J Clin Oncol2008，，：	1
14	Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high gradc non- Hodgkin's lymphoma and chronic lymphocytic leukemia 显示文摘	Yang H Rosove M H Figlin R A	1999	Am J Hematol1999，62，4：	1
15	The role of targeting mare-malian target of rapamycin in lung cancer显示文摘	Pal S K Figlin R A Reckamp K L	2008	Clin Lung Cancer2008，9，6：	1
16	Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin 显示文摘	RECKAMP K L GARDNER B K FIGLIN R A	2008	J Thorac Oncol2008，3，2：	1
17	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease显示文摘	JANZEN N K KIM H L FIGLIN R A	2003	Urol Clin North Am2003，30，4：	1
18	Surveillanceafter radical or partial nephrectomy for localized renalcell carcinoma and management of recurrent disease 显示文摘	Janzen N K Kim H L Figlin R A	2003	Urol Clin North Am2003，30，：	1
19	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease显示文摘	Janzen N K Kim H L Figlin R A	2003	Urol Clin North Am2003，30，4：	1
20	Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease 显示文摘	Janzen N K Kim H L Figlin R A	2003	Urol Clin North Am2003，30，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示